The Lung - a pivotal player in systemic inflammatory disorders
This symposium is arranged as a result of recent data on how smoking and genetic factors have a great impact - not only on the lungs but also on other organs affected in systemic inflammatory disorders. These findings call for more intensive collaborations in the future between clinicians representing different specialties' and for research of truly translational character.
Introductory speeches will be given to inform about common clinical findings which may reflect lung involvement in systemic disorders, and how they can be established. Smoking and co-morbidity in systemic inflammatory disorders will be discussed, and the role of interstitial lung involvement in myositis, rheumatoid arthritis and multiple sclerosis will be elucidated. Can smoking related changes in the lung trigger joint inflammation, or increase the risk of getting myositis or MS? Another topic is the genetic and possible etiological background in sarcoidosis.
Up-to-date treatment of interstitial lung involvement, pros and cons, and the effects of smoking on treatment will be debated followed by an overview of failures and successes of smoking cessation programs.
The number of participants is strongly limited, so register now.
Welcome!
Anders Eklund, Professor Pulmonary Unit and Ingrid Lundberg, Professor Rheumatology Unit. Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden.
Visit the symposium's official website for more information and registration.
For more information, please contact:
Jan Alvar Lindencrona
- E-post:
